Skip to main content
. 2007 May 19;17(5):622–630. doi: 10.1007/s11695-007-9106-2

Table 7.

Co-morbidities before VBG, and before and after RYGBP (group 1; N=74)

Comorbidity Before VBG Before RYGBP After RYGBP
Diabetes 5 (6.8%) 1 (1.4%) 0 (0%)
Hypertension 22 (29.7%) 12 (16.2%) 2 (2.7%)
Hypercholesterolemia 5 (6.8%) 2 (2.7%) 1 (1.4%)
Sleep apnea syndrome 7 (9.5%) 2 (2.7%) 0 (0%)
Joint problems 41 (55.4%) 30 (40.5%) 13 (17.6%)
Asthmatic complaints 12 (16.2%) 7 (9.5%) 1 (1.4%)
GERD 13 (17.6%) 15 (20.3%) 8 (10.8%)
Depression 22 (29.7%) 20 (27.0%) 11 (14.9%)